Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1988 Mar;59(3):287–291. doi: 10.1136/hrt.59.3.287

Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.

U Schmitz-Huebner 1, S G Thompson 1, L Balleisen 1, C Fechtrup 1, W Grosse-Heitmeyer 1, B Kirchhof 1, E Most 1, U S Müller 1, C Seiffert 1, D Seiffert 1, et al.
PMCID: PMC1216461  PMID: 3258521

Abstract

Blood samples were taken for haemostatic analysis from 225 patients with angina pectoris who were admitted to hospital for coronary angiography. beta thromboglobulin, platelet factor 3, platelet factor 4, factor VII:C, factor VIII:C, von Willebrand factor antigen, activated partial thromboplastin time, fibrinogen, antithrombin III, protein C:Ag, plasminogen, and antiplasmin were measured before angiography. Patients who had had a myocardial infarction in the two months before the investigation were excluded from the study. Multiple linear regression analysis showed that none of the haemostatic variables contributed independently to the prediction of an angiographic score that indicated the extent of coronary atherosclerosis. History of myocardial infarction, male sex, worsening of angina pectoris, serum triglycerides, and ejection fraction were independently associated with the angiographic score. There were some significant correlations between haemostatic variables and conventional risk factors for coronary heart disease. Thus data obtained from haemostatic analyses of peripheral venous blood do not permit the presence or the extent of atherosclerosis in coronary arteries to be predicted.

Full text

PDF
287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyer C., Rothschild C., Wolf M., Amiral J., Meyer D., Larrieu M. J. A new method for the estimation of protein C by ELISA. Thromb Res. 1984 Dec 15;36(6):579–589. doi: 10.1016/0049-3848(84)90197-x. [DOI] [PubMed] [Google Scholar]
  2. CLAUSS A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 Apr;17(4):237–246. doi: 10.1159/000205234. [DOI] [PubMed] [Google Scholar]
  3. DODGE H. T., SANDLER H., BALLEW D. W., LORD J. D., Jr The use of biplane angiocardigraphy for the measurement of left ventricular volume in man. Am Heart J. 1960 Nov;60:762–776. doi: 10.1016/0002-8703(60)90359-8. [DOI] [PubMed] [Google Scholar]
  4. Dalaker K., Hjermann I., Prydz H. A novel form of factor VII in plasma from men at risk for cardiovascular disease. Br J Haematol. 1985 Oct;61(2):315–322. doi: 10.1111/j.1365-2141.1985.tb02831.x. [DOI] [PubMed] [Google Scholar]
  5. Davies M. J., Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984 May 3;310(18):1137–1140. doi: 10.1056/NEJM198405033101801. [DOI] [PubMed] [Google Scholar]
  6. DeWood M. A., Spores J., Notske R., Mouser L. T., Burroughs R., Golden M. S., Lang H. T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980 Oct 16;303(16):897–902. doi: 10.1056/NEJM198010163031601. [DOI] [PubMed] [Google Scholar]
  7. Eisenberg P. R., Sherman L. A., Schectman K., Perez J., Sobel B. E., Jaffe A. S. Fibrinopeptide A: a marker of acute coronary thrombosis. Circulation. 1985 May;71(5):912–918. doi: 10.1161/01.cir.71.5.912. [DOI] [PubMed] [Google Scholar]
  8. Gallino A., Haeberli A., Baur H. R., Straub P. W. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia. Circulation. 1985 Jul;72(1):27–30. doi: 10.1161/01.cir.72.1.27. [DOI] [PubMed] [Google Scholar]
  9. Hamsten A., Wiman B., de Faire U., Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. 1985 Dec 19;313(25):1557–1563. doi: 10.1056/NEJM198512193132501. [DOI] [PubMed] [Google Scholar]
  10. Herman M. V., Heinle R. A., Klein M. D., Gorlin R. Localized disorders in myocardial contraction. Asynergy and its role in congestive heart failure. N Engl J Med. 1967 Aug 3;277(5):222–232. doi: 10.1056/NEJM196708032770502. [DOI] [PubMed] [Google Scholar]
  11. Judkins M. P. Percutaneous transfemoral selective coronary arteriography. Radiol Clin North Am. 1968 Dec;6(3):467–492. [PubMed] [Google Scholar]
  12. Kennedy J. W., Trenholme S. E., Kasser I. S. Left ventricular volume and mass from single-plane cineangiocardiogram. A comparison of anteroposterior and right anterior oblique methods. Am Heart J. 1970 Sep;80(3):343–352. doi: 10.1016/0002-8703(70)90099-2. [DOI] [PubMed] [Google Scholar]
  13. Kirchhof B., Balleisen L. Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay. Thromb Res. 1982 Aug 1;27(3):303–310. doi: 10.1016/0049-3848(82)90077-9. [DOI] [PubMed] [Google Scholar]
  14. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  15. Levine S. P., Lindenfeld J., Ellis J. B., Raymond N. M., Krentz L. S. Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion. Circulation. 1981 Sep;64(3):626–632. doi: 10.1161/01.cir.64.3.626. [DOI] [PubMed] [Google Scholar]
  16. Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986 Sep 6;2(8506):533–537. doi: 10.1016/s0140-6736(86)90111-x. [DOI] [PubMed] [Google Scholar]
  17. Meade T. W., Vickers M. V., Thompson S. G., Stirling Y., Haines A. P., Miller G. J. Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) 1985 Feb 9;290(6466):428–432. doi: 10.1136/bmj.290.6466.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nichols A. B., Owen J., Kaplan K. L., Sciacca R. R., Cannon P. J., Nossel H. L. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease. Blood. 1982 Sep;60(3):650–654. [PubMed] [Google Scholar]
  19. O'Connor N. T., Broekmans A. W., Bertina R. M. Protein C values in coronary artery disease. Br Med J (Clin Res Ed) 1984 Nov 3;289(6453):1192–1192. doi: 10.1136/bmj.289.6453.1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Odegård O. R. Evaluation of an amidolytic heparin cofactor assay method. Thromb Res. 1975 Aug;7(2):351–360. doi: 10.1016/0049-3848(75)90193-0. [DOI] [PubMed] [Google Scholar]
  21. Sobel M., Salzman E. W., Davies G. C., Handin R. I., Sweeney J., Ploetz J., Kurland G. Circulating platelet products in unstable angina pectoris. Circulation. 1981 Feb;63(2):300–306. doi: 10.1161/01.cir.63.2.300. [DOI] [PubMed] [Google Scholar]
  22. Teger-Nilsson A. C., Friberger P., Gyzander E. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest. 1977 Sep;37(5):403–409. [PubMed] [Google Scholar]
  23. White G. L., 2nd, Marouf A. A. Platelet factor 4 levels in patients with coronary artery disease. J Lab Clin Med. 1981 Mar;97(3):369–378. [PubMed] [Google Scholar]
  24. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]
  25. van Hulsteijn H., Kolff J., Briët E., van der Laarse A., Bertina R. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction. Am Heart J. 1984 Jan;107(1):39–45. doi: 10.1016/0002-8703(84)90131-5. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES